Allen is a visionary physician, neuroscientist, entrepreneur, and investor who has been a driving force in fostering innovation across Europe, the United States, and Asia. His ability to bridge the gap between academia and industry has made him an influential figure in the fields of life sciences, technology, and investment.
At RYSE Asset Management, Allen utilises venture capital investment as a catalyst to translate groundbreaking science into global impact. Leveraging his technical background as a surgeon and engineer, he has helped ventures to secure multimillion-dollar investments and gain entry into Silicon Valley's renowned accelerator, Y Combinator. Notably, he has led investor partnerships with the largest digital health accelerator in Europe, DigitalHealth.London, and with Novartis, Medtronic, and the NHS, driving the selection and rapid scaling of innovative early-stage companies that are transforming lives.
Allen is an NHS Governor at Cambridge University Hospitals, Board Advisor, including at Oto ā an innovative digital therapeutic company, and a member of The Royal Society of Medicine's Digital Health Council. His commitment to knowledge-sharing extends beyond boardrooms, as a Fellow at the University of Cambridge, visiting lecturer at University College London, the University of Oxford's Management in Medicine Programme, and Expert-in-Residence at Imperial College London's Business School where he recently published in Elsevier on the role of AI in the future of health that will be discussed in this keynote.